Assenagon Asset Management’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $685K | Sell |
|
|||||
|
2024
Q2 | $1.04M | Hold |
|
|||||
|
2024
Q1 | $971K | Sell |
|
|||||
|
2023
Q4 | $1.14M | Hold |
|
|||||
|
2023
Q3 | $3.43M | Buy |
|
|||||
|
2023
Q2 | $2.54M | Sell |
|
|||||
|
2023
Q1 | $4.96M | Buy |
|
|||||
|
2022
Q4 | $3.28M | Buy |
|
|||||
|
2022
Q3 | $2.05M | Sell |
|
|||||
|
2022
Q2 | $3.7M | Sell |
|
|||||
|
2022
Q1 | $4.34M | Buy |
|
|||||
|
2021
Q4 | $2.65M | Buy |
|
|||||
|
2021
Q3 | $2.4M | Buy |
|